Stay updated on SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial
Sign up to get notified when there's something new on the SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial page.

Latest updates to the SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial page
- Check6 days agoChange DetectedThe page content appears unchanged between the old and new screenshots, with all sections such as Study Details, Eligibility Criteria, and Locations remaining the same.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check35 days agoChange DetectedOverall, the page updates to announce a system status notice and a new software version (v3.2.0), removing the previous v3.1.0 reference.SummaryDifference1%

- Check42 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.0%

- Check49 days agoChange DetectedReplace Sage Therapeutics with Supernus Pharmaceuticals, Inc., and update last-update timestamps to reflect current information.SummaryDifference0.7%

- Check57 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

Stay in the know with updates to SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-547 Injection in SRSE: Adjunctive Therapy Clinical Trial page.